0001562180-24-002401.txt : 20240307
0001562180-24-002401.hdr.sgml : 20240307
20240307161839
ACCESSION NUMBER: 0001562180-24-002401
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blackley Richard Scott
CENTRAL INDEX KEY: 0001525020
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40154
FILM NUMBER: 24730381
MAIL ADDRESS:
STREET 1: 1680 CAPITAL ONE DRIVE
CITY: MCLEAN
STATE: VA
ZIP: 22102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oscar Health, Inc.
CENTRAL INDEX KEY: 0001568651
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 403-3677
MAIL ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: Mulberry Health Inc.
DATE OF NAME CHANGE: 20130204
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-03-05
false
0001568651
Oscar Health, Inc.
OSCR
0001525020
Blackley Richard Scott
75 VARICK STREET, 5TH FLOOR
NEW YORK
NY
10013
false
true
false
false
Chief Financial Officer
false
Class A Common Stock
2024-03-05
4
M
false
62500.00
A
641359.00
D
Class A Common Stock
2024-03-06
4
S
false
27043.00
14.12
D
614316.00
D
Restricted Stock Units
2024-03-05
4
M
false
62500.00
0.00
D
Class A Common Stock
62500.00
187500.00
D
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 to $14.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.
/s/ Melissa Curtin, Attorney-in-fact
2024-03-07